Matt Bennett, Managing Director, joined New Mountain in 2016. He focuses on growth transactions across several sectors including medical devices, pharmaceuticals, health technology, materials, and sustainable infrastructure. He serves on the Boards of HealthComp, Finvi, Real Chemistry, Covaris and Profile Products and works closely with additional NMC companies. He previously served on the Boards of Datavant, Gelest, Alteon, Sparta Systems, and Cytel.
Mr. Bennett was previously CEO of CIOX Health (now Datavant). Before that, he held multiple executive roles at Ikaria where he was Executive Vice President, Global Medical Operations, Chief Financial Officer, head of Corporate Development, and Chief Legal Officer. Prior to joining Ikaria, he was Executive Vice President, Chief Administrative Officer and Chief Business Officer, at VIASYS Healthcare, Inc. (NYSE: VAS), where he was responsible for the company’s growth strategy and mergers and acquisitions. Before VIASYS, he was a transaction leader on mergers and acquisitions, initial public offerings, and commercial transactions in health care at Morgan, Lewis & Bockius LLP, as well as a health care trial attorney at Stradley, Ronon, Stevens & Young.
He holds an AB in Political Science from Princeton University and a JD from Villanova University School of Law.